Abstract:Objective:To investigate the therapeutic effects of different low doses of mifepristone ( RU486 ) on adenomyosis women with dysmenorrhea so as to obtain an appropriate dose of RU486 for the treatment of adenomyosis. Methods:A total of 68 adenomyosis patients with dysmenorrhea were treated with 25mg RU486 weekly (group I:25mg/w,n=33),5mg RU486 daily (group II:5mg/d,n=24) and 2. 5mg RU486 daily (group III:2. 5mg/d,n=11) ,respectively. Before and after treatment,the uterine size,serum CA125 levels,VAS score, menstrual amounts,endometrial thickness and hemoglobin levels were analyzed comparatively. Results:Three and six months after treatment,the VAS scores and menstrual amounts in group I,II and III were all significantly lower than those before treatment (P<0. 05),while the hemo-globin levels were all significantly higher than those before treatment (P<0. 05). In group I,se-rum CA125 levels after treatment for 3 and 6 months were all lower than those before treatment ( P<0 . 05 ) , but no significant differences of uterine volume and endometrial thickness were found between 3 and 6 months after treatment (P>0. 05). In group II,serum CA125 levels and uterine volume after treatment for 3 months were both significantly lower than those before treat-ment(P<0. 05),and endometrial thickness after treatment for 6 months were significantly high-er than those before treatment (P<0. 05). However,serum CA125 levels or uterine volume after treatment for 6 months did not reach significant difference when compared with those before treatment(P>0. 05). In group III,serum CA125 levels and endometrial thickness after treat-ment for 6 months were both significantly higher than those before treatment (P<0. 05),but no significant difference of uterine volume between before and after treatment was found ( P>0 . 05 ) . Conclusions:These results suggest that different low doses of RU486 can be used to treat adenomyosis patients with dysmenorrhea effectively,but 25mg RU486 weekly might be the priority choice for the short-term treatment of adenomyosis with dysmenorrhea because it is con-venience,has long time interval and does not increase endometrial thickness.

Study on Effectiveness of Danazol-loaded Intrauterine Device in Treating Experimentally Induced Uterine Adenomyosis in the Mice

Evaluation of the efficacy of a danazol-loaded intrauterine contraceptive device on adenomyosis in an ICR mouse model.

The development of uterine adenomyosis induced by pituitary isografting in female ICR mice

Clinical Effectiveness and Potential Long-Term Benefits of High-Intensity Focused Ultrasound Therapy for Patients with Adenomyosis.

Investigation of the 12-Month Efficacy and Safety of Low-Dose Mifepristone in the Treatment of Painful Adenomyosis

The role of Danazol on the adhesion of ectopic endometrial cells to peritoneum in mice

Progress on Medical Treatment in the Management of Adenomyosis

Comparative analysis of the therapeutic effects of mifepristone with different low doses for the treatment of adenomyosis women with dysmenorrhea

Effect of Yiweining on rats with experimental endometriosis

Effect of danazol on NK cells and cytokines in the mouse uterus

Establishment of an ICR Mouse Model of Adenomyosis by Oral Administration of Tamoxifen

Proteomic Analysis of Uterine Tissues During Peri-Implantation Period in Mice with Experimentally Induced Adenomyosis that Treated with anti-Ngf: Implications for Cell-Cell Adhesion and Metabolic Processes

Shi Xiao San Ameliorates the Development of Adenomyosis in an ICR Mouse Model.

Adenomyosis in mice resulting from mechanically or thermally induced endometrial–myometrial interface disruption and its possible prevention

A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea

The model of uterine adenomyosis in mice induced by tamoxifen and the effect on fertility

Effect of andrographolide in experimental endometriosis models

Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis

Drug therapy and mechanism of pain in mice with induced adenomyosis

Impact of Uterine Adenomyosis on Pregnancy Outcomes in Women Undergoing In Vitro Fertilization Treated With a Long-Term Pituitary Downregulation Protocol

The glucagon-like peptide-1 (GLP-1) analog exenatide ameliorates intrauterine adhesions in mice